To really move the needle on 5-star ratings, leaders should meet with clinicians who are conducting OASIS assessments at key points including start of care, resumption of care, discharge or transfer.
Whether to transfer a patient with a discharge or without discharge has been causing much confusion among agencies in wake of the Patient-Driven Groupings Model (PDGM) implementation on Jan. 1.
Reeducate clinicians on the definition of “clinically significant” to help improve accuracy and potentially save time when responding to M2001 (Drug regimen review) and M2003 (Medication follow-up).
When responding to pressure ulcer items on the OASIS, clinicians can collaborate when only a partial skin assessment is completed on the first visit, according to the most recent release of CMS quarterly OASIS Q&As.
Following a recent DecisionHealth webinar about addressing the key challenges clinicians face with OASIS-D, agencies asked questions of industry expert Karen Tibbs, quality and education manager with Wayne, Pa.-based McBee Associates.
Ensure necessary diagnosis information is received within five days of a patient’s start of care (SOC) date, or risk forfeiting rightful reimbursement.
Collect information from multiple sources when responding to GG0110 (Prior device use). Doing so will help ensure more accurate responses.
When it comes to educating staff about how to respond to M1850 (Transferring), the key is paying close attention to the word “or” and how it’s used.
Agencies should establish policies for how to use a new valid response option coming to the OASIS beginning Jan. 1, 2020.
While OASIS-D1 will make responses to 23 existing items optional, agencies must keep in mind that the OASIS is only one piece of the assessment puzzle.


User Name: